CSIRO ICT Centre, The Australian e-Health Research Centre - BioMedIA, Level 7, UQ CCR Building 71/918, Royal Brisbane and Women's Hospital, Herston, Queensland QLD 4029, Australia.
Eye (Lond). 2009 Oct;23(10):1999-2005. doi: 10.1038/eye.2008.385. Epub 2008 Dec 19.
There has been accelerating progress in the development of retinal prosthesis systems designed to partially restore vision to people with retinitis pigmentosa or macular degeneration. Current retinal prostheses can be divided into two types: those that receive power and information from passive or active photodiodes (optoelectronic systems) and those based on multielectrode arrays powered by cables or transcutaneous telemetry systems. Currently, four research groups have ongoing chronic implantation clinical studies, and two of these groups plan to have commercial retinal prosthesis systems available within the next 2 years. This paper reviews the development and current status of the most significant international retinal prosthesis research groups and discusses future prospects and issues associated with their retinal prosthesis systems.
在为色素性视网膜炎或黄斑变性患者部分恢复视力而设计的视网膜假体系统的开发方面，已经取得了飞速的进展。目前的视网膜假体可以分为两类：一类是从无源或有源光电二极管（光电系统）接收电力和信息的，另一类是基于多电极阵列并由电缆或经皮遥测系统供电的。目前，有四个研究小组正在进行慢性植入临床研究，其中两个小组计划在未来 2 年内推出商业视网膜假体系统。本文回顾了国际上最重要的视网膜假体研究小组的发展和现状，并讨论了他们的视网膜假体系统的未来前景和相关问题。
